-
Vanderbilt Center for Technology Transfer and Commercialization
The CTTC transforms intellectual property into industry applications, fosters regional economic development through local licensing, and supports the creation of new ventures. -
Role of Patents in Vanderbilt Research: Insights from CTTC's Lunch and Learn
By navigating existing patents, purchasing licenses, or exploring alternative technologies, faculty researchers can proceed without legal hurdles. -
Transforming Obesity Care Through AI and Industry Collaborations
A $1 million grant from Eli Lilly and Company will fund a two-year project intended to bridge the gaps in obesity treatment by leveraging AI technologies at Vanderbilt University Medical Center. -
Revolutionizing Research Data Management: Paul Harris’s RedCap Journey
What began as a practical solution to a local challenge has transformed into REDCap (Research Electronic Data Capture), a worldwide research phenomenon. -
Vanderbilt announces Innovation Catalyst Fund awardees for June 2025 cycle
Vanderbilt has announced nine awardees in the latest round of its Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential -
Vanderbilt CTTC drives record innovation impact in FY25
Vanderbilt CTTC had an exceptional 2025 fiscal year, setting all-time records across multiple metrics while expanding the university's innovation impact. -
Vanderbilt Innovation Ambassadors Program Bridges Gap Between Research and Commercialization
Vanderbilt’s Innovation Ambassadors Program is transforming how academic discoveries translate into societal impact through a peer-to-peer approach that has become a model for universities nationwide. -
Vanderbilt Innovation Catalyst Fund continues advancing research with new review committee
The Vanderbilt Innovation Catalyst Fund bridges the gap between academic research and real-world applications by supporting projects with commercial and societal potential -
Turning Research into Real-World Impact: New Lunch & Learn Series for Faculty
This fall, the Center for Technology Transfer and Commercialization (CTTC) is launching a new Lunch and Learn series designed to help faculty translate their research discoveries into meaningful, real-world applications. Through this series, researchers will gain valuable insights into innovation,… -
Vanderbilt-Discovered Compound Advances to Phase 1 Clinical Trial as a Promising New Treatment for Schizophrenia
Neumora Therapeutics, Inc. has announced the launch of a Phase 1 clinical study evaluating NMRA-861 in healthy adult participants and adults with stable schizophrenia.